PeptideStack
5.2kquestions
20kanswers
220users

My cagrilintide vial sat at 37 °C for seven days — is testing worth it before use?

Asked 6 Apr 2026Modified 15 days agoViewed 10k times
20

What I have: cagrilintide · 37 °C · seven days.

This is a planning question. I know what my options are; I do not know how to weigh them.

What I want is the minimum viable version, which I suspect is smaller than what I would design.

How do I make this decision on evidence rather than on feel?

cold-chain
cold-chain

Keeping material within a temperature window from manufacture to use: phase-change packs versus dry ice, thermal mass, transit-lane temperature…

578 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questions
amylin
amylin

Amylin and its analogues, most prominently cagrilintide, as a satiety mechanism orthogonal to incretin signalling. Includes the pharmacology of…

237 questions
shareeditfollowflag
TW
askedtare_weight60k1486 Apr 2026

5 Answers

Accepted answer first, then by votes
26

Accepted answer

Seven days at 37 °C is about 64 refrigerated days of equivalent exposure. 37 °C is 32 kelvin above the 5 °C middle of a 2–8 °C refrigerator. The ten-degree rule of thumb — degradation rate roughly doubling per 10 K — makes that about 9.2 times the refrigerated rate, which is an order-of-magnitude statement and not a shelf life. At 64 equivalent days a test is more likely to reassure you than to tell you something, which is a legitimate reason to run it and a poor reason to expect a finding. Either way, record the seven days and the temperature now, while you still know them; an excursion you did not write down is an excursion you cannot interpret later.

The relevant physics is latent heat: a phase-change pack holds temperature only while it is changing phase, and once it has melted it is a warm mass.

A pack that arrived hard tells you about the last day of transit only, since it will have melted and, if the ambient dropped, partially refrozen.

More usefully, anything shipped in solution is a different risk category, because hydrolysis and deamidation proceed in the aqueous phase and are strongly temperature-dependent.

Phase-change pack hold time is a function of mass, latent heat and insulation, and published figures for small parcels are on the order of one to two days.

Lyophilised tolerates the lane. That is the answer for almost every order.

edited 15 Jul 2026 by lane_transit — clarified the distinction between purity and content

shareimprove this answerflag
LT
answered · acceptedlane_transit60k478 Jul 2026
6Is there a reason to prefer minus eighty here, or is minus twenty genuinely enough? – u100_marks 10 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
10

The short version: a spent cold pack on arrival is expected, the solid does not mind, and the pack was never going to last twelve days.

Arrhenius behaviour means the degradation rate roughly doubles per ten degrees. A week at thirty degrees is therefore a meaningful exposure for a solution and an immaterial one for a dry solid.

Worth being precise here: that is the argument for shipping lyophilised rather than for shipping colder. A dry powder with low residual moisture is stable at ambient for months; the pathways that matter need water.

Buy a logger if you actually want to know. Everything else is inference.

shareimprove this answerflag
BC
answeredbea_castellanos24k1272 Jun 2026
5I have kept vials both ways for a year and this matches what I saw. – eoin_mcgarry 3 months ago
4Aliquoting before the first freeze is the advice I wish I had read two years ago. – deamidation_watch 2 months ago
add a comment
8

Start with the physical state, because it changes the answer completely and is the first thing to establish.

A single-use temperature logger costs a few pounds, records the whole journey and converts an argument into a record. If the history matters, this is the answer.

Stated carefully, asking a supplier to hold a shipment during a heatwave is reasonable and the better ones agree; the cost is a week and the benefit is a shorter warm exposure for anything in solution.

Solutions are a different question and deserve the worry the solids get.

shareimprove this answerflag
KA
answeredkwn_analytical147k35826 May 2026
7

If temperature history matters to you, buy a data logger. It is the only way to know.

A single phase-change pack in a thin-walled box holds below ten degrees for roughly one to two days at twenty-five degrees ambient, and under a day at thirty-five. On a nine-to-fourteen-day lane the material is at ambient for most of the journey whatever was packed with it.

Arrhenius kinetics predict approximately a doubling of degradation rate per ten-degree rise and are the standard basis for cold-chain design.

The caveat is that a warm transit is survivable for a solid and materially different for a solution.

The domestic leg is the part you control. Refrigerate it promptly.

shareimprove this answerflag
FC
answeredforty_two_c66k5820 Apr 2026
6

Specifically, the domestic leg after arrival is the part most often left in a warm hallway and least often worried about.

Once the parcel arrives, the domestic leg is the controllable part: get it into the refrigerator promptly rather than leaving it in a warm hallway for a day.

Reconstituted material has a genuine cold-chain requirement and it starts the moment water is added.

A liquefied pack is expected. It is not evidence of a problem.

shareimprove this answerflag
KS
answeredk_szabo27k279 Jun 2026

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.